APX

1.92%

76.5¢ appen limited

Very good idea! In extending products offering into Medical...

First 60 Last

Share
Profile

Follow
redbaron

2,038 Posts.

82

04/06/21

20:19

Post #: 53660333
Share

Originally posted by Zenox: ↑

Definitely kill the dividend since this is a growth stock (and is treated like one by the market).

Incorporate medical research / and other research disciplines into their product offerings to help clean and annotate data for research organisations (as opposed to focusing solely on commercial enterprise/govt etc). This should be one of their product arms and is a massive market since it aligns with data science projects, which requires high quality annotated data. A question along these lines was asked at the investor tech day but no-one on the panel truly understood what was being asked.

Invest in their dataset offerings.

Aquire early-stage companies (not mature companies) that can help Appen compete and propel them forward.

Create a spin-off that will appeal more to the younger audience, since CEO's of tech companies are getting younger and younger. Scale AI appeals to a younger, more tech savvy audience, whereas Appen appears more stale on this front.

Look to add new directors who have experience operating at the executive level of market leading companies, since they know what it takes to remain a market leader. Appen needs to double down on its position as a market leader and continue to create and execute on its strategy. It seems Appen have simply sat back and enjoyed their unbridled success and rested on their laurels, when they should've been working hard to stay in front and dominate. The restructuring is an acknowledgement of this, but the need to be doing more, a lot more.

Expand

Very good idea! In extending products offering into Medical research, Pathological detections....etc.
it just may come at a cost with experts annotations!
GLA

APX Price at posting: $12.24 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

WGX

Westgold sets its sights on top five producer status through merger with Karora

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

GRX

GreenX picks up prospective copper project in Germany

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

There are more pages in this discussion • 1 more message in this thread...

First 60 Last

Add APX (ASX) to my watchlist

(20min delay)
Last 76.5¢		Change -0.015(1.92%)		Mkt cap ! $170.5M

Open	High	Low	Value	Volume
75.0¢	82.0¢	74.0¢	$16.84M	21.56M

Buyers (Bids)

No.	Vol.	Price($)
2	10668	75.5¢

Sellers (Offers)

Price($)	Vol.	No.
76.5¢	23269	4

View Market Depth

No.	Vol.	Price($)
2	10668	0.755
2	4297	0.750
8	113177	0.745
11	113495	0.740
4	46901	0.735

Price($)	Vol.	No.
0.765	23269	4
0.770	55319	5
0.775	73550	5
0.780	58319	3
0.785	45057	3

Last trade - 16.10pm 02/08/2024 (20 minute delay)

APX (ASX) Chart

Very good idea! In extending products offering into Medical...

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Westgold sets its sights on top five producer status through merger with Karora

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

GreenX picks up prospective copper project in Germany

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Very good idea! In extending products offering into Medical...

Top Stories

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Westgold sets its sights on top five producer status through merger with Karora

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Venture to sniff out high-grade REE targets at Jupiter project, WA

Is oil undervalued?

GreenX picks up prospective copper project in Germany

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News